Key facts
- It has raised $72.0M; the latest was Early Stage VC ($72.0M) in Jul 2024.
- Notable investors include MSD Global Health Innovation Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for N-Power Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for N-Power Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About N-Power Medicine
Operator of a biotechnology company intended to accelerate oncology innovation. The company leverages a network of community oncology centers equipped with qualified staff to identify suitable patients for research studies, enabling pharmaceutical companies and researchers to conduct trials faster and potentially reach a more diverse pool of participants.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2021
- Employees
- 114
- Website
- npowermedicine.com/
- Ownership
- Privately Held (backing)
N-Power Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in N-Power Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on N-Power Medicine in its N-PORT filings yet. We sweep new filings monthly.